View the latest SAMU supported publications from 2022
Articles include:
From Q1:
- Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India
- Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis
- Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?
- Implementing a Substance-Use Screening and Intervention Program for People Living with Rifampicin-Resistant Tuberculosis: Pragmatic Experience from Khayelitsha, South Africa
- HIV Self-testing Among Previously Diagnosed HIV-Positive People in Khayelitsha, South Africa: No Evidence of Harm but may Facilitate Re-engagement in ART Care
- Early mortality during rifampicin-resistant TB treatment
- Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a crosssectional and longitudinal study
- Provision of Decentralized TB Care Services: A Detect–Treat–Prevent Strategy for Children and Adolescents Affected by TB
- Attrition from HIV care among youth initiating ART in youth-only clinics compared with general primary healthcare clinics in Khayelitsha, South Africa: a matched propensity score analysis
From Q2:
- Feasibility and acceptability of using the novel urine-based FujiLAM test to detect tuberculosis: A multi-country mixed-methods study
- Being heard on all-oral therapy for resistant tuberculosis
- Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study
- DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series
- Prevalence of TB and health-seeking behaviour
- Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa
- Engineering a sustainable future for point-of-care diagnostics and single-use microfluidic devices: Lab on a chip